Stock Scorer

VitaNova Life Sciences Corp (VNOV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 700K 1.4M 2.1M Q1 '22: 0 Q2 '22: 45K Q3 '22: 30K Q4 '22: 45K Q1 '23: 15K Q2 '23: 10K Q3 '23: 10K Q4 '23: 3K Q1 '24: 0 Q2 '24: 0 Q3 '24: 26.1K Q4 '24: 544.6K Q1 '25: 108.5K Q2 '25: 292.1K Q3 '25: 308.3K Q4 '25: 2M Q1 '26: 103.9K Q2 '26: 427.1K Q3 '26: 709.6K Q4 '26: 1.8M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit Quarterly

-400K 0 400K 800K 1.2M Q1 '18: 15.5K Q2 '18: 19.9K Q3 '18: 0 Q4 '18: -35.4K Q1 '19: 0 Q2 '19: 5.9K Q3 '19: 0 Q4 '19: -5.9K Q1 '24: 0 Q2 '24: 0 Q3 '24: 26.1K Q4 '24: 351.6K Q1 '25: 73.2K Q2 '25: 155.8K Q3 '25: 189.3K Q4 '25: 1.2M Q1 '26: 68.8K Q2 '26: 260.8K Q3 '26: 316.3K Q4 '26: 264.7K Q2 '18 Q1 '19 Q4 '19 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating Income Quarterly

-400K 0 400K 800K 1.2M Q4 '20: -26.3K Q1 '21: -11.2K Q2 '21: -12.4K Q3 '21: -2.9K Q4 '21: -25.6K Q1 '22: -10.5K Q2 '22: -30K Q1 '23: 2.1K Q1 '24: -24.2K Q2 '24: -8.8K Q3 '24: 5.9K Q4 '24: 232.7K Q1 '25: -45.4K Q2 '25: 62.6K Q3 '25: 108.9K Q4 '25: 1.1M Q1 '26: -32.4K Q2 '26: 99.2K Q3 '26: 46.7K Q4 '26: -109.9K Q1 '21 Q4 '21 Q1 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Net Income Quarterly

-300K 0 300K 600K 900K Q4 '21: -25.6K Q1 '22: 142.6K Q2 '22: 15K Q3 '22: 8.9K Q1 '23: 2.1K Q2 '23: 2.6K Q3 '23: -24.6K Q4 '23: -4.4K Q1 '24: -24.2K Q2 '24: -8.8K Q3 '24: 5.9K Q4 '24: 167.9K Q1 '25: -55.2K Q2 '25: 32.6K Q3 '25: 73K Q4 '25: 800.3K Q1 '26: -46.3K Q2 '26: 35.8K Q3 '26: -44.4K Q4 '26: 17.5K Q1 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue Quarterly

0 600K 1.2M 1.8M Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 193K Q1 '25: 35.3K Q2 '25: 136.3K Q3 '25: 119K Q4 '25: 795.8K Q1 '26: 35.1K Q2 '26: 166.3K Q3 '26: 393.3K Q4 '26: 1.5M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Cash Flow Quarterly

-600K -400K -200K 0 200K 400K 600K Q1 '22: -6.9K Q2 '22: 19.6K Q3 '22: 5.2K Q4 '22: -13.8K Q1 '23: 6.8K Q2 '23: 5.3K Q3 '23: -28.2K Q4 '23: -2.3K Q1 '24: -26.1K Q2 '24: -8K Q3 '24: -150.6K Q4 '24: -191.2K Q1 '25: -504K Q2 '25: 8.8K Q3 '25: 208.9K Q4 '25: 479.1K Q1 '26: 263.8K Q2 '26: 212.7K Q3 '26: -90.4K Q4 '26: 428.3K Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '18: 4.1M Q3 '18: 5.9M Q1 '19: 5.9M Q2 '19: 5.9M Q3 '19: 5.9M Q1 '22: 5.9M Q2 '22: 5.9M Q3 '22: 5.9M Q1 '23: 5.9M Q2 '23: 5.9M Q3 '23: 5.9M Q1 '24: 5.9M Q2 '24: 5.9M Q3 '24: 6.1M Q1 '25: 25M Q2 '25: 25M Q3 '25: 8.3M Q1 '26: 25M Q2 '26: 25M Q3 '26: 8.3M Q3 '18 Q3 '19 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.01 0.00 0.01 0.03 0.04 Q1 '22: 0.01 Q2 '22: 0.01 Q3 '22: 0.01 Q4 '22: 0.02 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.01 Q1 '25: 0.01 Q2 '25: 0.01 Q3 '25: 0.02 Q4 '25: 0.03 Q1 '26: 0.03 Q2 '26: 0.03 Q3 '26: 0.01 Q4 '26: -0.00 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for VNOV: Free Cash Flow. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.